1. Comments on Waldeyer et al. 'Response to Hex et al. Estimating the current and future costs for Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs'. Issue 4 (17th March 2013) Authors: Hex, N.; Taylor, M.; Bartlett, C. Journal: Diabetic medicine Issue: Volume 30:Issue 4(2013:Apr.) Page Start: 503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit. Issue 11 (15th April 2016) Authors: Baxter, M.; Hudson, R.; Mahon, J.; Bartlett, C.; Samyshkin, Y.; Alexiou, D.; Hex, N. Journal: Diabetic medicine Issue: Volume 33:Issue 11(2016:Nov.) Page Start: 1575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of candidate‐gene CNTNAP2 in childhood apraxia of speech and specific language impairment. Issue 7 (19th June 2015) Authors: Centanni, T. M.; Sanmann, J. N.; Green, J. R.; Iuzzini‐Seigel, J.; Bartlett, C.; Sanger, W. G.; Hogan, T. P. Journal: American journal of medical genetics Issue: Volume 168:Issue 7(2015) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The role of the virtual MDT in risk stratification of lung cancer referrals. (January 2020) Authors: Uys, S.; Nixon, R.; Ricketts, W.; Castle, L.; Bartlett, C.; Low, B.; Sherpa, G.; Thompson, E. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗